Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001213900-14-000347
Filing Date
2014-01-21
Accepted
2014-01-21 16:04:35
Documents
1
Effectiveness Date
2014-01-21
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 12013
  Complete submission text file 0001213900-14-000347.txt   13212
Mailing Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017
Business Address 501 FIFTH AVENUE, 3RD FLOOR NEW YORK NY 10017 212-300-2131
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-209458 | Film No.: 14538081
SIC: 6770 Blank Checks